Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Babaoglu, Jianjun Qi, Richard Lee, S. White (2004)
Crystal structure of 7,8-dihydropteroate synthase from Bacillus anthracis: mechanism and novel inhibitor design.Structure, 12 9
H. Chambers (2005)
Community-associated MRSA--resistance and virulence converge.The New England journal of medicine, 352 14
K. Frey, JieYing Liu, M. Lombardo, David Bolstad, D. Wright, A. Anderson (2009)
Crystal structures of wild-type and mutant methicillin-resistant Staphylococcus aureus dihydrofolate reductase reveal an alternate conformation of NADPH that may be linked to trimethoprim resistance.Journal of molecular biology, 387 5
J. Szumowski, D. Cohen, F. Kanaya, K. Mayer (2006)
Treatment and Outcomes of Infections by Methicillin-Resistant Staphylococcus aureus at an Ambulatory ClinicAntimicrobial Agents and Chemotherapy, 51
J. Błaszczyk, G. Shi, Yue Li, Honggao Yan, X. Ji (2004)
Reaction trajectory of pyrophosphoryl transfer catalyzed by 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase.Structure, 12 3
B. Matthews (1968)
Solvent content of protein crystals.Journal of molecular biology, 33 2
Collaborative Computational (1994)
The CCP4 suite: programs for protein crystallography.Acta crystallographica. Section D, Biological crystallography, 50 Pt 5
B. Xiao, G. Shi, X. Chen, H. Yan, X. Ji (1999)
6-HYDROXYMETHYL-7,8-DIHYDROPTERIN PYROPHOSPHOKINASE
Michael Hennig, Glenn Dale, A. D'arcy, Franck Danel, Stefan Fischer, Christopher Gray, S. Jolidon, F. Müller, Malcolm Page, Philip Pattison, C. Oefner (1999)
The structure and function of the 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Haemophilus influenzae.Journal of molecular biology, 287 2
R. Proctor (2008)
Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 46 4
J. Swarbrick, P. Iliades, J. Simpson, I. Macreadie (2008)
Folate Biosynthesis – Reappraisal of Old and Novel Targets in the Search for New AntimicrobialsThe Open Enzyme Inhibition Journal, 1
R. Drew (2007)
Emerging Options for Treatment of Invasive, Multidrug‐Resistant Staphylococcus aureus InfectionsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 27
(1992)
Jnt CCP4/ESF-EACBM Newsl. Protein Crystallogr. 26. Luft
E. Lescop, Zhenwei Lu, Qin Liu, Huimin Xu, Guangyu Li, B. Xia, Honggao Yan, C. Jin (2009)
Dynamics of the conformational transitions in the assembling of the Michaelis complex of a bisubstrate enzyme: a (15)N relaxation study of Escherichia coli 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase.Biochemistry, 48 2
Alun Bermingham, J. Derrick (2002)
The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery.BioEssays : news and reviews in molecular, cellular and developmental biology, 24 7
J. Davies (1994)
Inactivation of antibiotics and the dissemination of resistance genes.Science, 264 5157
Mitchell Cohen (1994)
Antimicrobial resistance: prognosis for public health.Trends in microbiology, 2 10
J. Luft, G. DeTitta (1999)
A method to produce microseed stock for use in the crystallization of biological macromolecules.Acta crystallographica. Section D, Biological crystallography, 55 Pt 5
V. Schirch, W. Strong (1989)
Interaction of folylpolyglutamates with enzymes in one-carbon metabolism.Archives of biochemistry and biophysics, 269 2
(1992)
Science, 257, 1050–1055
(1992)
Jnt CCP 4 / ESF – EACBM Newsl
M. Adra, K. Lawrence (2004)
Trimethoprim/Sulfamethoxazole for Treatment of Severe Staphylococcus aureus InfectionsAnnals of Pharmacotherapy, 38
H. Nikaido (1994)
Prevention of drug access to bacterial targets: permeability barriers and active efflux.Science, 264 5157
J. Newman, Tam Pham, T. Peat (2008)
Phoenito experiments: combining the strengths of commercial crystallization automation.Acta crystallographica. Section F, Structural biology and crystallization communications, 64 Pt 11
Mitchell Cohen (1992)
Epidemiology of Drug Resistance: Implications for a Post—Antimicrobial EraScience, 257
J. Derrick (2008)
The structure and mechanism of 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase.Vitamins and hormones, 79
H. Neu (1992)
The Crisis in Antibiotic ResistanceScience, 257
6‐Hydroxymethyl‐7,8‐dihydropterin pyrophosphokinase (HPPK) catalyzes the Mg2+‐dependent transfer of pyrophosphate from ATP to 6‐hydroxymethyl‐7,8‐dihydropterin (HMDP), forming 6‐hydroxymethyl‐7,8‐dihydropterin pyrophosphate, which is a critical step in the de novo folic acid‐biosynthesis pathway. Diffraction‐quality crystals of HPPK from the medically relevant species Staphylococcus aureus were grown in the presence of ammonium sulfate or sodium malonate and diffracted to better than 1.65 Å resolution. The crystals belonged to space group P21, with unit‐cell parameters a = 36.8, b = 76.6, c = 51.5 Å, α = γ = 90.0, β = 100.2°. The crystals contained two molecules per asymmetric unit, with a volume per protein weight (VM) of 2.04 Å3 Da−1 and an estimated solvent content of 39.6%.
Acta Crystallographica Section F – Wiley
Published: May 1, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.